name,sponsor,study,resultsDate
"Oxford-AstraZeneca COVID-19 vaccine (Vaxzevria, Covishield)","University of Oxford, AstraZeneca, CEPI","Phase III (30,000) Interventional; randomized, placebo-controlled study for efficacy, safety, and immunogenicity.",2020-12-08
"Pfizer-BioNTech COVID-19 vaccine (Comirnaty)","BioNTech, Pfizer","Phase III (43,998) Randomized, placebo-controlled. Positive results from an interim analysis were announced on 18 November 2020 Germany, United States",2020-11-18
"Janssen COVID-19 vaccine","Janssen Vaccines (Johnson & Johnson), BIDMC","Phase III (40,000) Randomized, double-blinded, placebo-controlled Positive results from an interim analysis were announced on 29 January 2021. J&J reports an efficacy of 66% against mild and moderate symptoms, and 85% against severe symptoms.",2021-01-29
"Moderna COVID-19 vaccine (Spikevax)","Moderna, NIAID, BARDA, CEPI","Phase III (30,000) Interventional; randomized, placebo-controlled study for efficacy, safety, and immunogenicity. Positive results from an interim analysis were announced on 16 November 2020 Jul 2020 - Oct 2022, United States",2020-11-16
